P7208-50UG Display Image

Pertussis toxin from Bordetella pertussis, lyophilized powder

Code: P7208-50UG D2-231

Application

The toxin is released from B. pertussis in an inactive form. When the pertussis toxin B oligomer binds to the cell membrane, the S1 subunit of its A prot...


read more

Your Price
£629.00 50UG
£754.80 inc. VAT

Application

The toxin is released from B. pertussis in an inactive form. When the pertussis toxin B oligomer binds to the cell membrane, the S1 subunit of its A protomer becomes activated, perhaps through the action of glutathione and ATP. A protocol for activating pertussis toxin in vitro is given by Kaslow, et al.

Biochem/physiol Actions

Pertussis toxin catalyzes the ADP-ribosylation of the α subunits of the heterotrimeric guanine nucleotide regulatory proteins Gi, Go, and Gt. This prevents the G protein heterotrimers from interacting with receptors, thus blocking their coupling and activation. Since the Gα subunits remain in their GDP-bound, inactive state, they are unable to inactivate adenylyl cyclase or open K+ channels.

Features and Benefits

This compound is featured on the G Proteins (Heterotrimeric) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

General description

Product is not activated. If activation is required, see Kaslow, et al., for suggested conditions.

Physical form

Lyophilized powder containing sodium chloride and sodium phosphate buffer salts

formlyophilized powder
Gene InformationBordetella pertussis Tohama I ... ptxA(2665068), ptxB(2665069), ptxC(2665408)
Quality Level200
storage temp.2-8°C
Cas Number70323-44-3
This product has met the following criteria: